What happens when cell analysis moves beyond simply measuring more to understanding more?
In the latest episode of PharmaShots CXO Talks, Wenbin Jiang, CEO and Chairman of the Board, and William McCombe, Chief Financial Officer, Cytek Biosciences, explore how advances in flow cytometry, AI, imaging, and cloud-based analytics are reshaping the way researchers understand cells.
At the center of the conversation is full-spectrum flow cytometry, Cytek’s approach to capturing more of the information generated during experiments and enabling increasingly complex, high-parameter analysis.
Wenbin takes us through Cytek’s technology journey and the evolution of cell analysis, while highlighting how AI-enabled tools, imaging, and Cytek Cloud can help researchers streamline workflows, design panels, and turn increasingly complex datasets into actionable insights.
William offers a business perspective on the opportunity ahead, discussing Cytek’s technology leadership, market expansion, and investment priorities across areas including minimal residual disease (MRD), cell and gene therapy, instrument replacement, and reagents.
The conversation also underscores a critical element behind innovation: close relationships with customers and strategic collaborators. As cell analysis becomes more sophisticated, understanding what researchers need next may be just as important as developing the technology itself.
Watch the Full Conversation
Click below to watch the full PharmaShots CXO Talks conversation with Wenbin Jiang and William McCombe and discover how Cytek Biosciences is shaping the next chapter of cell analysis.
About the Authors
Wenbin Jiang, Ph.D.
CEO and Chairman of the Board
Wenbin Jiang, Ph.D. has served as Cytek’s Chief Executive Officer and a member of board of directors since December 2014 and serves as chair of the board. Dr. Jiang is also a co-founder of the company. In 1998, Dr. Jiang co-founded E2O Communications, Inc., a fiber optic subsystems manufacturing company, which was acquired by JDS Uniphase Corporation in 2004. Dr. Jiang is an inventor of more than 100 U.S. patents and an author of five book chapters and over 50 peer-reviewed technical papers. Dr. Jiang holds a B.S. in Physics and a M.S. in Optics & Laser Physics from Fudan University and a Ph.D. in Electrical Engineering from University of California, Santa Barbara.
Dr. Jiang is currently serving on the Board of Trustees of the UC Santa Barbara Foundation and the Director’s Council in the Institute for Energy Efficiency at UC Santa Barbara.
William McCombe
Chief Financial Officer
William McCombe has served as the Chief Financial Officer of Cytek since March 2024. Prior to joining Cytek, Mr. McCombe served as Chief Financial Officer at Velo3D Inc., a leader in metal 3D printing systems, from August 2020 to September 2023 and as Chief Financial Officer at HZO, Inc., a leader in delivering nano coatings for electronics, from 2018 to 2020. Mr. McCombe also previously served as Chief Financial Officer at Maxar Technologies Inc., a multi-billion-dollar revenue satellite and space imaging company, from 2016 to 2018. Mr. McCombe also has over 20 years of experience in investment banking, having served as Managing Director, Mergers and Acquisitions, at Bank of America Merrill Lynch and Morgan Stanley. Mr. McCombe holds an M.B.A. from Columbia University Graduate School of Business and a Bachelor of Laws and Commerce from the University of Melbourne.
